Skip to main content
Top
Published in: International Journal of Legal Medicine 1/2007

01-01-2007 | Case Report

Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders

Authors: Vittorio Fineschi, Irene Riezzo, Fabio Centini, Enrico Silingardi, Manuela Licata, Giovanni Beduschi, Steven B. Karch

Published in: International Journal of Legal Medicine | Issue 1/2007

Login to get access

Abstract

We report two cases of sudden cardiac death (SCD) involving previously healthy bodybuilders who were chronic androgenic–anabolic steroids users. In both instances, autopsies, histology of the organs, and toxicologic screening were performed. Our findings support an emerging consensus that the effects of vigorous weight training, combined with anabolic steroid use and increased androgen sensitivity, may predispose these young men to myocardial injury and even SCD.
Literature
1.
go back to reference Sullivan ML, Martinez CM, Gennis P, Gallagher EJ (1998) The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41:1–15CrossRefPubMed Sullivan ML, Martinez CM, Gennis P, Gallagher EJ (1998) The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41:1–15CrossRefPubMed
2.
go back to reference Delbeke FT, Desmet N, Debackere M (1995) The abuse of doping agents in competing body builders in Flanders (1988–1993). Int J Sports Med 16:66–70PubMed Delbeke FT, Desmet N, Debackere M (1995) The abuse of doping agents in competing body builders in Flanders (1988–1993). Int J Sports Med 16:66–70PubMed
3.
go back to reference Scarpino V, Arrigo A, Benzi G, Garattini S, La Vecchia C, Bernardi LR et al (1990) Evaluation of prevalence of “doping” among Italian athletes. Lancet 336:1048–1050CrossRefPubMed Scarpino V, Arrigo A, Benzi G, Garattini S, La Vecchia C, Bernardi LR et al (1990) Evaluation of prevalence of “doping” among Italian athletes. Lancet 336:1048–1050CrossRefPubMed
4.
go back to reference Ferrara SD (2004) Doping antidoping. Piccin, Padua Ferrara SD (2004) Doping antidoping. Piccin, Padua
5.
go back to reference Melchert RB, Welder AA (1995) Cardiovascular effects of androgenic–anabolic steroids. Med Sci Sports Exerc 27:1252–1262PubMed Melchert RB, Welder AA (1995) Cardiovascular effects of androgenic–anabolic steroids. Med Sci Sports Exerc 27:1252–1262PubMed
6.
go back to reference Sheppard M, Davies MJ (1998) Practical cardiovascular pathology. Arnold, London Sheppard M, Davies MJ (1998) Practical cardiovascular pathology. Arnold, London
7.
go back to reference Karch SB (1998) Drug abuse handbook. CRC, Boca Raton Karch SB (1998) Drug abuse handbook. CRC, Boca Raton
8.
go back to reference Schänzer W, Donike M (1993) Metabolism of anabolic steroids in man: synthesis and the use of reference substances for identification of anabolic steroid metabolites. Anal Chim Acta 275:23–48CrossRef Schänzer W, Donike M (1993) Metabolism of anabolic steroids in man: synthesis and the use of reference substances for identification of anabolic steroid metabolites. Anal Chim Acta 275:23–48CrossRef
9.
go back to reference Luke JL, Farb A, Virmani R, Sample RHB (1990) Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroid: pathological and toxicological findings. J Forensic Sci 35:1441–1447PubMed Luke JL, Farb A, Virmani R, Sample RHB (1990) Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroid: pathological and toxicological findings. J Forensic Sci 35:1441–1447PubMed
10.
go back to reference Welder AA, Robertson JW, Melchert RB (1995) Toxic effects of anabolic–androgenic steroids in primary rat hepatic cell cultures. J Pharmacol Toxicol Methods 33:187–195CrossRefPubMed Welder AA, Robertson JW, Melchert RB (1995) Toxic effects of anabolic–androgenic steroids in primary rat hepatic cell cultures. J Pharmacol Toxicol Methods 33:187–195CrossRefPubMed
11.
go back to reference Zimmerman HJ, Ishak KG (2002) Hepatic injury due to drugs and toxins. In: MacSween RNM (ed) Pathology of the liver. Churchill Livingstone, London, pp 621–709 Zimmerman HJ, Ishak KG (2002) Hepatic injury due to drugs and toxins. In: MacSween RNM (ed) Pathology of the liver. Churchill Livingstone, London, pp 621–709
12.
go back to reference Soe KL, Soe M, Gluud CN (1992) Liver pathology associated with the use of anabolic–androgenic steroids. Liver 12:73–79PubMed Soe KL, Soe M, Gluud CN (1992) Liver pathology associated with the use of anabolic–androgenic steroids. Liver 12:73–79PubMed
13.
go back to reference Mewis C, Spyridopoulos I, Kuhlkamp V, Seipel L (1996) Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol 19:153–155PubMed Mewis C, Spyridopoulos I, Kuhlkamp V, Seipel L (1996) Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol 19:153–155PubMed
14.
go back to reference Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ (1998) Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98:256–261PubMed Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ (1998) Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98:256–261PubMed
15.
go back to reference Hausmann R, Hammer S, Betz P (1998) Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Leg Med 111:261–264CrossRef Hausmann R, Hammer S, Betz P (1998) Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Leg Med 111:261–264CrossRef
16.
go back to reference Lyndberg KK (1991) Myokardieinfarkt og ded af bodybuilder behandlet ned anabole steroider. Ugeskr Laeger 153:587–589PubMed Lyndberg KK (1991) Myokardieinfarkt og ded af bodybuilder behandlet ned anabole steroider. Ugeskr Laeger 153:587–589PubMed
17.
go back to reference Fineschi V, Baroldi G, Monciotti F, Paglicci Reattelli L, Turillazzi E (2001) Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med 125:253–255PubMed Fineschi V, Baroldi G, Monciotti F, Paglicci Reattelli L, Turillazzi E (2001) Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med 125:253–255PubMed
18.
go back to reference Urhausen A, Hoples R, Kindermann W (1989) One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol 58:633–640CrossRef Urhausen A, Hoples R, Kindermann W (1989) One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol 58:633–640CrossRef
19.
go back to reference Urhausen A, Albers T, Kindermann W (2004) Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 90:496–501CrossRefPubMed Urhausen A, Albers T, Kindermann W (2004) Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 90:496–501CrossRefPubMed
20.
go back to reference Dickerman RD, Schaller F, Prather I, McConathy WJ (1995) Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86:172–173PubMedCrossRef Dickerman RD, Schaller F, Prather I, McConathy WJ (1995) Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86:172–173PubMedCrossRef
21.
go back to reference Baroldi G, Fineschi V, Silver MD, Parolini M, Mittleman RE (2001) Myocardial contraction bands. Definition, quantification and significance. Int J Leg Med 115:142–151CrossRef Baroldi G, Fineschi V, Silver MD, Parolini M, Mittleman RE (2001) Myocardial contraction bands. Definition, quantification and significance. Int J Leg Med 115:142–151CrossRef
22.
go back to reference Urhausen A, Weller B, Coen B, Kindermann W (1994) Plasma catecholamines during endurance exercise of different intensities as related to individual anaerobic threshold. Eur J Appl Physiol 69:16–20CrossRef Urhausen A, Weller B, Coen B, Kindermann W (1994) Plasma catecholamines during endurance exercise of different intensities as related to individual anaerobic threshold. Eur J Appl Physiol 69:16–20CrossRef
23.
go back to reference Pomara C, D’Errico S, Riezzo I, de Cillis GP, Fineschi V (2005) Sudden cardiac death in a child affected by Prader–Willi syndrome. Int J Leg Med 119:153–157CrossRef Pomara C, D’Errico S, Riezzo I, de Cillis GP, Fineschi V (2005) Sudden cardiac death in a child affected by Prader–Willi syndrome. Int J Leg Med 119:153–157CrossRef
24.
go back to reference Bloch W (2002) Anabolic steroids alter cardiac adaptation to exercise. In: Peters C, Schulz T, Michna H (eds) Biomedical side effects of doping. Verlag Sport und Buch Strauß, Köln, pp 51–59 Bloch W (2002) Anabolic steroids alter cardiac adaptation to exercise. In: Peters C, Schulz T, Michna H (eds) Biomedical side effects of doping. Verlag Sport und Buch Strauß, Köln, pp 51–59
25.
26.
go back to reference Hausmann R (2005) Long-term effects of anabolic–androgenic-steroid abuse: morphological findings associated with fatal outcome. In: Tsokos M (ed) Forensic pathology reviews, vol. 2. Humana, Totowa, pp 273–289 Hausmann R (2005) Long-term effects of anabolic–androgenic-steroid abuse: morphological findings associated with fatal outcome. In: Tsokos M (ed) Forensic pathology reviews, vol. 2. Humana, Totowa, pp 273–289
Metadata
Title
Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders
Authors
Vittorio Fineschi
Irene Riezzo
Fabio Centini
Enrico Silingardi
Manuela Licata
Giovanni Beduschi
Steven B. Karch
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
International Journal of Legal Medicine / Issue 1/2007
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-005-0055-9

Other articles of this Issue 1/2007

International Journal of Legal Medicine 1/2007 Go to the issue